Indoleamine 2,3-dioxygenase (IDO) activity is lower in atopic than in non-atopic individuals and is enhanced by environmental factors protecting from atopy
Authors:
- 1 March 2006
- journal article
- research article
- Published by Elsevier in Molecular Immunology
- Vol. 43 (7) , 1054-1056
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Ido expression by dendritic cells: tolerance and tryptophan catabolismNature Reviews Immunology, 2004
- Inhibition of experimental asthma by indoleamine 2,3-dioxygenaseJournal of Clinical Investigation, 2004
- Tryptophan Catabolism and Regulation of Adaptive ImmunityThe Journal of Immunology, 2003
- Quantification of indoleamine 2,3-dioxygenase gene induction in atopic and non-atopic monocytes after ligation of the high-affinity receptor for IgE, FcɛRI and interferon-γstimulationClinical and Experimental Immunology, 2003
- Hygiene hypothesis: Fact or fiction?Journal of Allergy and Clinical Immunology, 2003
- Longitudinal study of tryptophan degradation during and after pregnancyLife Sciences, 2003
- The IL1A genotype associates with atopy in nonasthmatic adultsJournal of Allergy and Clinical Immunology, 2002
- More Rapid Method for Simultaneous Measurement of Tryptophan and Kynurenine by HPLCClinical Chemistry, 2002